WO2006055417A3 - Methods for the therapeutic use of cyclosporine components - Google Patents

Methods for the therapeutic use of cyclosporine components Download PDF

Info

Publication number
WO2006055417A3
WO2006055417A3 PCT/US2005/040926 US2005040926W WO2006055417A3 WO 2006055417 A3 WO2006055417 A3 WO 2006055417A3 US 2005040926 W US2005040926 W US 2005040926W WO 2006055417 A3 WO2006055417 A3 WO 2006055417A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
oral
conditions
therapeutic use
cyclosporine
Prior art date
Application number
PCT/US2005/040926
Other languages
French (fr)
Other versions
WO2006055417A2 (en
Inventor
Michael E Stern
David Power
Original Assignee
Allergan Inc
Michael E Stern
David Power
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc, Michael E Stern, David Power filed Critical Allergan Inc
Publication of WO2006055417A2 publication Critical patent/WO2006055417A2/en
Publication of WO2006055417A3 publication Critical patent/WO2006055417A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Methods of treating humans or animals having various conditions are disclosed which include administering a cyclosporine component. Among the conditions treated are dry mouth syndrome, verruciform xanthoma, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, cancer of the oral mucosa, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, duodenal ulcers, peptic ulcers, conditions affecting the uterus and appendicitis.
PCT/US2005/040926 2004-11-15 2005-11-11 Methods for the therapeutic use of cyclosporine components WO2006055417A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/990,054 US7135455B2 (en) 2004-11-15 2004-11-15 Methods for the therapeutic use of cyclosporine components
US10/990,054 2004-11-15

Publications (2)

Publication Number Publication Date
WO2006055417A2 WO2006055417A2 (en) 2006-05-26
WO2006055417A3 true WO2006055417A3 (en) 2006-08-24

Family

ID=36000815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/040926 WO2006055417A2 (en) 2004-11-15 2005-11-11 Methods for the therapeutic use of cyclosporine components

Country Status (2)

Country Link
US (4) US7135455B2 (en)
WO (1) WO2006055417A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095486A1 (en) * 2006-02-13 2007-08-23 Allergan, Inc. Methods of treating blepharospasm using cyclosporine components
WO2013181339A2 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
SE445174B (en) 1978-03-07 1986-06-09 Sandoz Ag PHARMACEUTICAL COMPOSITION CONTAINING A CYCLOSPORIN AND A HEALING SUBSTANCE
FR2561919B1 (en) * 1984-04-03 1986-12-19 Roussel Uclaf PHARMACEUTICAL COMPOSITION CONSTITUTED ON THE ONE HAND, AS ACTIVE INGREDIENT, BY 9A, 11B-DICHLORO 16A-METHYL 21-OXYCARBONYLDICYCLOHEXYL METHYLOXY PREGNA-1,4-DIENE 3,20-DIONE AND ON THE OTHER HAND, BY A PHARM EXCIPIENT INERTE CAPABLE OF ALLOWING THE ACTION OF THE PRODUCT IN THE RECTUM OR THE COLON
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4814323A (en) 1986-03-25 1989-03-21 Andrieu J M Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
JPH0667850B2 (en) 1987-09-03 1994-08-31 ユニバーシティ オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Ophthalmic cyclosporin composition
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
GB8729153D0 (en) 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
DE68900991D1 (en) 1988-01-29 1992-04-23 Sankyo Co CYCLOSPORIN COMPOSITIONS.
CH679119A5 (en) 1988-05-13 1991-12-31 Sandoz Ag
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5540931A (en) 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
EP0484281B2 (en) 1990-11-02 2000-11-22 Novartis AG Cyclosporins
GB9105705D0 (en) 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
IL102236A0 (en) 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
US5286731A (en) 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory bowel disease
US5286730A (en) 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
JP3631490B2 (en) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 Cyclosporine-containing ophthalmic composition
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
PT589843E (en) 1992-09-25 2002-04-29 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
US5843452A (en) 1992-11-09 1998-12-01 Pharmagenesis, Inc. Immunotherapy composition and method
NZ247516A (en) 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
US6323204B1 (en) 1993-10-13 2001-11-27 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US6022852A (en) 1993-10-22 2000-02-08 Hexal Ag Pharmaceutical composition containing cyclosporin A
US5891846A (en) 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
WO1995032726A1 (en) 1994-06-01 1995-12-07 Yuhan Corporation Cyclosporin containing composition and process for the preparation thereof
ES2177652T3 (en) 1994-11-03 2002-12-16 Novartis Ag NEW FORMS OF PREPARATION OF CYCLOSPORINE FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY, AND PROCEDURE FOR OBTAINING IT.
US6696413B2 (en) 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
CZ288631B6 (en) 1996-01-18 2001-08-15 Galena, A. S. Therapeutic preparations containing cyclosporin
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
US20020025925A1 (en) * 1996-09-20 2002-02-28 Wood Lars Michael Combination therapy
DE69828496T2 (en) 1997-03-12 2006-03-23 Abbott Laboratories, Abbott Park HYDROPHILINE BINARY SYSTEMS FOR THE ADMINISTRATION OF CYCLOSPORIN
NZ314702A (en) 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
JP4761093B2 (en) * 1997-12-10 2011-08-31 シクロスポリン セラポイティクス リミテッド Pharmaceutical composition comprising omega-3 fatty acid oil
US5981607A (en) 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
DE19810655A1 (en) 1998-03-12 1999-09-16 Univ Eberhard Karls Pharmaceutical composition containing cyclosporin A suitable for topical administration for treating disorders of skin, mucosa and eyes
AU5093899A (en) * 1998-07-07 2000-01-24 Hisamitsu Pharmaceutical Co. Inc. Antisense oligonucleotides targeted to il-15
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
ATE250924T1 (en) * 2000-04-07 2003-10-15 Medidom Lab EYE MEDICINAL CONTAINING CYCLOSPORINE, HYALURONIC ACID AND POLYSORBATES
US6784156B2 (en) 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
US6713081B2 (en) * 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
DE60237363D1 (en) * 2001-03-15 2010-09-30 Soligenix Inc METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES OF DIGESTIVE STRENGTH WITH TOPIC EFFECTIVE CORTICOSTEROIDS
WO2002098376A1 (en) 2001-06-06 2002-12-12 The Regents Of The University Of Michigan Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
US7033604B2 (en) 2001-07-06 2006-04-25 Sucampo Ag Composition for topical administration
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
US20030087813A1 (en) 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
WO2004036182A2 (en) * 2002-10-17 2004-04-29 Control Delivery Systems, Inc. Methods for monitoring treatment of disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GAETA G M ET AL: "Cyclosporin bioadhesive gel in the topical treatment of erosive oral lichen planus", INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, vol. 7, no. 2, 1994, pages 125 - 132, XP008061800, ISSN: 0394-6320 *
SANDBORN WILLIAM J ET AL: "Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis", AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 88, no. 5, 1993, pages 640 - 645, XP008061801, ISSN: 0002-9270 *

Also Published As

Publication number Publication date
US7368426B2 (en) 2008-05-06
US20060199760A1 (en) 2006-09-07
US20090298753A1 (en) 2009-12-03
US20080076707A1 (en) 2008-03-27
US20060105944A1 (en) 2006-05-18
WO2006055417A2 (en) 2006-05-26
US7135455B2 (en) 2006-11-14

Similar Documents

Publication Publication Date Title
TW200727910A (en) Therapeutic methods using cyclosporine components
IL245955B (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
DE60327438D1 (en) AMINO-SUBSTITUTED CYCLOHEXAN DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
WO2004094596A8 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2006096173A8 (en) Pharmaceutical compositions and methods for peptide treatment
HRP20080438T3 (en) Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
PL1638938T3 (en) Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
NO20055187D0 (en) Procedures for the treatment and prevention of lower urinary tract symptoms
WO2006055417A3 (en) Methods for the therapeutic use of cyclosporine components
IL153359A0 (en) Peptides, compositions and methods for the treatment of burkholderia cepacia
EP1651255A4 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2002226030A1 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2003049804A3 (en) Treatment of genitourinary tract disorders
WO2002065989A3 (en) Aminoglycoside treatment for lysosomal storage diseases
WO2005060960A3 (en) Use of histamine to treat bone disease
WO2000051582A3 (en) Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
WO2003097050A3 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
AU7882600A (en) Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
WO2003063927A3 (en) Compositions and methods to treat gastrointestinal disorders
WO2005039483A3 (en) Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
EA200801890A1 (en) MEANS FOR THE TREATMENT OF NOISE IN THE EARS
MXPA03003032A (en) Combination therapy for the treatment of estrogen-sensitive disease.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05851542

Country of ref document: EP

Kind code of ref document: A2